Frazier Life Sciences Management’s AnaptysBio ANAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-1,573,719
Closed -$20.8M 48
2024
Q4
$20.8M Sell
1,573,719
-635,470
-29% -$15.4M 0.86% 25
2024
Q3
$74M Buy
2,209,189
+43,598
+2% +$1.49M 2.97% 13
2024
Q2
$54.3M Buy
2,165,591
+1,265,891
+141% +$29.5M 2.54% 12
2024
Q1
$20.3M Hold
899,700
0.85% 31
2023
Q4
$19.3M Hold
899,700
1.03% 27
2023
Q3
$16.2M Hold
899,700
1.07% 22
2023
Q2
$18.3M Hold
899,700
1.09% 22
2023
Q1
$19.6M Hold
899,700
1.42% 19
2022
Q4
$27.9M Hold
899,700
1.73% 14
2022
Q3
$23M Hold
899,700
1.77% 16
2022
Q2
$18.3M Hold
899,700
1.72% 16
2022
Q1
$22.3M Buy
+899,700
New +$27.2M 1.9% 17

Other funds holding ANAB